The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...

Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with ...

In fibrotic ILD, desaturation recovery post 6MWT is linked to disease progression, baseline disease severity, and transplant-free survival.

Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

"Nurses kept coming by to see him because usually people don't live through his specific type of break. He had to have a halo for a while (think Regina George after the bus), and recovery was not fun, ...

A machine learning model incorporating functional assessments predicts one-year mortality in older patients with HF and improves risk stratification beyond established scores. Functional status at ...

Aims The obesity paradox has been described in different cardiovascular conditions. Data on the association between obesity and outcomes in patients with Takotsubo syndrome (TTS) are lacking. The aim ...

Objectives This study examined discharge outcomes and their predictors among patients enrolled in remote patient monitoring (RPM) support in Ontario, Canada. Design A 6-month competing risk survival ...

Background Congenital heart disease (CHD) is the leading congenital cause of death in newborns worldwide. Approximately ...